Literature DB >> 17020561

Age-based differences of percutaneous coronary intervention in the drug-eluting stent era.

Kevin C Floyd1, John E Jayne, Aaron V Kaplan, Bruce J Friedman, Nathaniel W Niles, Bruce D Hettleman, John F Robb, Craig A Thompson.   

Abstract

INTRODUCTION: Limited data are available on contemporary percutaneous coronary intervention (PCI) practice patterns and outcomes in elderly patients. The objective of this study was to evaluate "real-world" PCI in elderly and nonelderly patients during the first year of availability of drug-eluting stents (DES) in the United States market (May 1, 2003-April 30, 2004).
METHODS: One thousand one hundred sixty-six consecutive patients (272 elderly [age > or =75 years] and 894 nonelderly [age <75 years]) having PCI for de novo coronary artery disease (CAD) at Dartmouth-Hitchcock Medical Center were included in this study. Primary outcome measures of this study were in-hospital major adverse cardiac events (MACE-death, new MI, urgent revascularization). Secondary end points included acute renal failure, respiratory failure, and vascular complications.
RESULTS: Elderly patients had higher MACE (8.5% vs 1.5%, P < or = 0.001), unadjusted in-hospital mortality (7.4% vs 0.8%, P < or = 0.001), in-hospital cardiac arrest (1.5% vs 0.3%, P = 0.03), requirements for assisted blood pressure support (13.2% vs 7.0%, P = 0.0001), respiratory failure (2.2% vs 0.9%, P = 0.08), acute renal failure (2.9% vs 0.8%, P = 0.005), and vascular complications (10.3% vs 5.5%, P = 0.005) than their nonelderly counterparts. Higher MACE rates persisted in the elderly despite correction for baseline differences using multivariate regression modeling.
CONCLUSIONS: Advanced age remains a predictor of adverse outcomes attending PCI even in the contemporary era in which DES are available. This study highlights the need for further progress and investigation to optimize outcomes of PCI in the elderly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020561     DOI: 10.1111/j.1540-8183.2006.00192.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  7 in total

1.  Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).

Authors:  Kevin R Bainey; Faith Selzer; Howard A Cohen; Oscar C Marroquin; Elizabeth M Holper; Michelle M Graham; David O Williams; David P Faxon
Journal:  Am J Cardiol       Date:  2011-10-14       Impact factor: 2.778

2.  Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry.

Authors:  Paolo Buja; Davide Lanzellotti; Giambattista Isabella; Massimo Napodano; Marco Panfili; Enrico Favaretto; Sabino Iliceto; Giuseppe Tarantini
Journal:  Heart Vessels       Date:  2011-10-12       Impact factor: 2.037

3.  Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.

Authors:  Heli M Lahtela; Aissa Bah; Tuomas Kiviniemi; Wail Nammas; Axel Schlitt; Andrea Rubboli; Pasi P Karjalainen; Marco Proietti; Juha E K Hartikainen; Gregory Y H Lip; K E Juhani Airaksinen
Journal:  Clin Cardiol       Date:  2017-12-15       Impact factor: 2.882

4.  Successful percutaneous coronary intervention in a centenarian patient with acute myocardial infarction.

Authors:  Ki Hong Lee; Myung Ho Jeong; Cho Yun Chung; Donghan Kim; Min Goo Lee; Keun-Ho Park; Doo Sun Sim; Nam Sik Yoon; Hyun Ju Yoon; Kye Hun Kim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  Korean Circ J       Date:  2012-05-24       Impact factor: 3.243

5.  Characteristics, in-hospital and long-term clinical outcomes of nonagenarian compared with octogenarian acute myocardial infarction patients.

Authors:  Ki Hong Lee; Youngkeun Ahn; Sung Soo Kim; Si Hyun Rhew; Young Wook Jeong; Soo Young Jang; Jae Yeong Cho; Hae Chang Jeong; Keun-Ho Park; Nam Sik Yoon; Doo Sun Sim; Hyun Joo Yoon; Kye Hun Kim; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Jeong Gwan Cho; Jong Chun Park; Myung Ho Jeong; Myeong-Chan Cho; Chong Jin Kim; Young Jo Kim
Journal:  J Korean Med Sci       Date:  2014-04-01       Impact factor: 2.153

6.  Percutaneous Coronary Intervention Outcomes Based on Decision-Making Capacity.

Authors:  Jarmanjeet Singh; Nicholas Kassis; Keerat R Ahuja; Chirag Sheth; Beni R Verma; Saket Saxena; Amar Krishnaswamy; Stephen Ellis; Jaikirshan Khatri; Venu Menon; Samir R Kapadia
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 5.501

7.  Safety and efficacy of a non-polymeric paclitaxel-eluting microporous stent in real-world percutaneous coronary intervention.

Authors:  Shao-Peng Wang; Rong-Chong Huang; Hao Zhu; Bo Zhang; Zhen-Guo Zheng; DA Yin; Jun-Jie Wang; Xu-Chen Zhou
Journal:  Exp Ther Med       Date:  2013-07-11       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.